Rep. Katie Porter @RepKatiePorter
And did Big Pharma use the tax cuts they received in the Trump tax law for research and development? Of course not. These companies have made $73 billion in buybacks from the Trump tax law, far more than some have spent on research and development. (5/6) https://t.co/7VBpFFJKUx — PolitiTweet.org